Market revenue in 2023 | USD 36.6 million |
Market revenue in 2030 | USD 154.1 million |
Growth rate | 22.8% (CAGR from 2023 to 2030) |
Largest segment | Predictive testing |
Fastest growing segment | Predictive Testing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Nutrigenomics Testing, Predictive Testing, Carrier Testing, Other Test Types |
Key market players worldwide | 23andMe Holding Co Class A, Genesis Healthcare Inc Class A, Bureau Veritas SA, Myriad Genetics Inc, Color, Living DNA, Full Genomes, EasyDNA, Ancestry, Family Tree DNA, Nanobiomatters Industries, Milliken & Company, Biocote, Microban International, SteriTouch, Sanitized |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to direct-to-consumer genetic testing market will help companies and investors design strategic landscapes.
Predictive testing was the largest segment with a revenue share of 37.7% in 2023. Horizon Databook has segmented the India direct-to-consumer genetic testing market based on nutrigenomics testing, predictive testing, carrier testing, other test types covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the India direct-to-consumer genetic testing market , including forecasts for subscribers. This country databook contains high-level insights into India direct-to-consumer genetic testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account